US 12,264,415 B2
Polycaprolactone-based fibers and implants including same
Bhavin B. Shah, West Lafayette, IN (US); Benjamin Patrick Kline, Lafayette, IN (US); and Rhonda Peck, West Lafayette, IN (US)
Assigned to Cook Biotech Incorporated, West Lafayette, IN (US)
Filed by Cook Biotech Incorporated, West Lafayette, IN (US)
Filed on Sep. 1, 2023, as Appl. No. 18/459,805.
Application 18/459,805 is a continuation of application No. 16/893,777, filed on Jun. 5, 2020, granted, now 11,746,443.
Claims priority of provisional application 62/858,560, filed on Jun. 7, 2019.
Prior Publication US 2024/0068131 A1, Feb. 29, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. D01F 6/62 (2006.01); A61L 27/18 (2006.01); A61L 29/06 (2006.01); A61L 31/06 (2006.01); D02J 1/20 (2006.01)
CPC D01F 6/625 (2013.01) [A61L 27/18 (2013.01); A61L 29/06 (2013.01); A61L 31/06 (2013.01); D02J 1/20 (2013.01); D10B 2331/041 (2013.01); D10B 2401/061 (2013.01); D10B 2509/00 (2013.01)] 21 Claims
OG exemplary drawing
 
1. A melt extruded, oriented polymeric material fiber, wherein the polymeric material is a homopolymer of caprolactone or a copolymer of at least 90% by weight of caprolactone and one or more additional monomers; and wherein:
(i) the polymeric material fiber has a tensile strength of about 450 MPa to about 650 MPa; and
(ii) the polymeric material fiber has an elongation at break in the range of 45% to 65%.